Skip to main content

ADVERTISEMENT

comparative-effectiveness researcher

04/22/2016
JCP Editors
A lack of randomized controlled trials (RCTs) shouldn’t rule out the use of effective treatment strategies, such as stereotactic ablative radiotherapy (SABR), for lung cancer, urged a prominent oncologist recently....
A lack of randomized controlled trials (RCTs) shouldn’t rule out the use of effective treatment strategies, such as stereotactic ablative radiotherapy (SABR), for lung cancer, urged a prominent oncologist recently....
A lack...
04/22/2016
Journal of Clinical Pathways